JNJ JOHNSON & JOHNSON Earnings Reports 8-K Filing 2024 - Earnings Report Johnson & Johnson reported a quarterly earnings increase of 5% year-over-year, totaling $23.8 billion in revenue, driven by strong sales in its pharmaceutical segment.Get access to all SEC 8-K filings of the JOHNSON & JOHNSON